Chemical activators of RWDD2A can engage multiple cellular signaling pathways to elicit functional activation of the protein. Phorbol 12-myristate 13-acetate, commonly known as PMA, directly activates protein kinase C (PKC), which in turn can phosphorylate RWDD2A, leading to its functional enhancement. This activation process is a classic example of signal transduction involving PKC, which plays a pivotal role in various cellular processes. Similarly, Forskolin raises intracellular cAMP levels, thereby activating protein kinase A (PKA). The activation of PKA can result in the phosphorylation of RWDD2A or its associated proteins, thus promoting RWDD2A's activity. Ionomycin, as another example, increases intracellular calcium concentrations, subsequently activating calmodulin-dependent kinases that can also target RWDD2A for phosphorylation. This phosphorylation serves as a regulatory mechanism, changing the functional state of the protein.
Another cAMP analog, 8-Bromo-cAMP, emulates the action of Forskolin by activating PKA, with the same potential for RWDD2A activation through phosphorylation. Okadaic Acid and Calyculin A, both inhibitors of protein phosphatases, lead to the accumulation of phosphorylated proteins, including RWDD2A, therefore activating it. Anisomycin triggers the MAP kinase pathway, which can result in the activation of RWDD2A through the action of MAP kinases. Thapsigargin, by inducing endoplasmic reticulum stress, may activate RWDD2A through the unfolded protein response, a complex network of signaling pathways aiming to restore normal cell function. Bisindolylmaleimide I, although a PKC inhibitor, can at low concentrations activate PKC, leading to downstream phosphorylation and activation of RWDD2A. Dibutyryl-cAMP, another cAMP analog, activates PKA, which might directly phosphorylate RWDD2A, thus promoting its activation. Lithium Chloride, by inhibiting GSK-3, can lead to the activation of RWDD2A by preventing inhibitory phosphorylation. Lastly, Staurosporine, a well-known PKC activator, can facilitate the phosphorylation and subsequent activation of RWDD2A, adding to the repertoire of chemical activators that utilize phosphorylation as a means to modulate RWDD2A activity.
VER TAMBIÉN ....
Items 1 to 10 of 11 total
Mostrar:
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activador directo de la proteína quinasa C (PKC) que puede fosforilar la RWDD2A dando lugar a su activación. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Aumenta los niveles de calcio intracelular, activando indirectamente las quinasas dependientes de calmodulina que podrían fosforilar y activar la RWDD2A. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
Un análogo del AMPc que activa la PKA, lo que conduce a la fosforilación potencial de RWDD2A, dando lugar a su activación. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibidor de las proteínas fosfatasas 1 y 2A, lo que provoca un aumento de la fosforilación y, por tanto, de la activación de proteínas, incluida la RWDD2A. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibe las proteínas fosfatasas, lo que conduce a la activación de RWDD2A a través de un aumento de la fosforilación. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activa la vía MAP quinasa, lo que podría conducir a la activación de RWDD2A a través de la fosforilación por MAP quinasas. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induce estrés de RE que conduce a la activación de la respuesta a proteínas no plegadas que puede activar RWDD2A a través de vías de señalización celular adaptativa. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibidor específico de la PKC que a bajas concentraciones puede activar paradójicamente la PKC, dando lugar a una activación descendente de la RWDD2A a través de la fosforilación. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Un análogo del AMPc que activa la PKA; la PKA puede entonces fosforilar y activar la RWDD2A. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibe la glucógeno sintasa quinasa-3 (GSK-3), lo que podría conducir a la activación de RWDD2A a través de la reducción de la fosforilación inhibitoria. | ||||||